Prognostic evaluation of elevation of cardiac biomarkers after myocardial revascularization. Long-term follow-up of MASS-V trial.

27 August 2018 (11:18 - 11:27)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Eduardo Martins

University of Sao Paulo, Sao Paulo (Brazil)

9 More presentations in this session

Presentation thumbnail

Implementation of a specific safety checklist in cardiac surgery is followed by lower postoperative mortality.

Mr A. Spanjersberg (Zwolle, NL)

Abstract Slides Video

Presentation thumbnail

Effect of nutritional status on mortality in patients undergoing coronary artery bypass grafting

Doctor M. Keskin (Istanbul, TR)

Abstract Slides Video

Presentation thumbnail

Role of a rapid point-of-care platelet function test on bleeding risk prediction in patients undergoing coronary artery bypass grafting surgery

Doctor A. Tello Montoliu (El Palmar, ES)

Presentation thumbnail

Preoperatively continued aspirin in elective isolated coronary-artery bypass grafting: a single institutional propensity score matched study

Mr J. Qu (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human epicardial and intramyocardial coronary arteries of male patients undergoing coronary artery bypass grafting

Doctor A. Karanasos (Patras, GR)

Abstract Slides Video

Access the full session

Session thumbnail

Risk management in cardiac surgery

The Event

ESC Congress 2018

27 August 2018 11:18 CET

You may be interested in

Congress Presentation

Case 2 - left main revascularisation: dilemmas and clinical implementation - the Israeli perspective

Congress Presentation

2024 ESC Guidelines on Chronic Coronary Syndromes: case presentation

Congress Presentation

Abnormal origination of all coronary arteries from the right sinus of Valsalva

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources